Lauren Biscaldi, MS

Suicides among health care professionals are estimated to occur at a higher rate than in the general public.

Although there were some differences in response after dosing, both OTC and oral prescriptions demonstrated statistically significant improvements in pain.

Bivalent COVID-19 vaccines by both Moderna and Pfizer-BioNTech are no longer authorized for use in the United States.

Charitable patient assistance foundations do crucial work to help individuals access necessary health care.

The 2023 Healthcare Advocate Summit is September 5 to 9 in New Orleans, Louisiana.

Readers, we want to hear from you!

Legal challenges have made dispensing abortion medications more difficult than ever.

Did you miss this year’s NACDS Total Store Expo? Check out the first part of our Conference Recap.

It's an exciting time for policies being made around food as medicine.

Only 4% of money for research and development is used to focus on women’s health issues.

Generative AI is the fastest growing technology ever, and is anticipated to be adopted faster than the world wide web.

Illinois Governor JB Pritzker signed into a law a bill prohibiting PBM retaliation against pharmacists who disclose information during government proceedings.

Catch up on the latest pharmacy issues and trends with Doug Long, vice president of industry relations at IQVIA.

What can pharmacists do to bring innovative care models into their stores to serve their communities?

After sessions end, head out to explore the city of San Diego.

The NACDS Total Store Expo takes place August 12 through 14, 2023 in San Diego, California.

Approximately 1 in 8 women in the United States experience postpartum depression.

Zavegepant (Zavzpret) is the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray approved by the FDA for acute migraine treatment in adults.

The Equitable Community Access to Pharmacy Services legislation was introduced earlier this year in the House of Representatives.

NCPA, NACDS, and APhA have joined the Healthcare Distribution Alliance in calling for a delay in the implementation of DSCSA.

The COVID-19 public health emergency is over. What happens now?

These medications join adalimumab-atto, which launched on January 31.

Continuous glucose monitor and insulin pump use improved HbA1c.

The company has been working since 2015 to implement the track and trace elements required by the Drug Supply Chain Security Act.